New Delhi, Sep 29 (UNI) India's pharmaceutical sector has received a potential tariff reprieve from

New Delhi, Sep 29 (UNI) India's pharmaceutical sector has received a potential tariff reprieve from the US, with Washington exempting select medicines and related manufacturing components from import duties. The exemption covers India and 19 other partner jurisdictions as the US moves to impose a 100 percent tariff on certain patented pharmaceutical products. The US Commerce Department has notified the eligible countries and product categories through the Federal Register. Under the framework, qualifying products imported from the listed jurisdictions will attract a zero per cent tariff if they fall within the scope of an existing or upcoming trade and security…